Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Dal-Ré

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
BMJ Open|July 26, 2019
Editors' and authors' individual conflicts of interest disclosure and journal transparency. A cross-sectional study of high-impact medical specialty journalsRafael Dal-Ré, Arthur L Caplan, Ana Marusic
Basic & Clinical Pharmacology & Toxicology|July 2, 2026
Contribution of Countries and International Collaboration in Clinical Pharmacology Research. A Cross-Sectional Bibliometric Study of Six Top Ranked Specialty Society JournalsRafael Dal-Ré, Lucía Llanos, Ignacio Mahillo-Fernández
European Journal of Clinical Pharmacology|September 14, 2017
Who is willing to participate in low-risk pragmatic clinical trials without consent?Rafael Dal-Ré, Antonio J Carcas, Xavier Carné
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 8, 2022
Heterologous COVID-19 Vaccination in Spain: A Case Study of Individual Autonomy in the Real WorldRafael Dal-Ré, Magí Farré, M Isabel Lucena
Journal of Global Health|January 19, 2023
How WHO Solidarity Plus trial participants in countries on four continents are informed in writingRafael Dal-Ré, Teck Chuan Voo, Søren Holm
Journal of Global Health|May 11, 2023
Adaptive, platform trials assessing therapies for hospitalized COVID-19 patients: Informed consent forms omitted a few important elements of informationRafael Dal-Ré, Teck Chuan Voo, Søren Holm
BMC Medicine|April 5, 2018
Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?Rafael Dal-Ré, Perrine Janiaud, John P A Ioannidis
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|March 23, 2021
Thoughtful selection and use of scientific terms in clinical research: the case of 'pragmatic' trialsRafael Dal-Ré, Robert J Mentz, Frits R Rosendaal
European Journal of Clinical Pharmacology|January 9, 2025
Features and results availability of non-commercial Spanish COVID-19 trials: a systematic review of clinical trial registers and corresponding literatureRafael Dal-Ré, Elena García-Méndez, Ignacio Mahillo-Fernández
British Journal of Clinical Pharmacology|January 9, 2016
The potential exploitation of research participants in high income countries who lack access to health careRafael Dal-Ré, Annette Rid, Ezekiel Emanuel, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
BMJ Open|July 26, 2019
Editors' and authors' individual conflicts of interest disclosure and journal transparency. A cross-sectional study of high-impact medical specialty journalsRafael Dal-Ré, Arthur L Caplan, Ana Marusic
Basic & Clinical Pharmacology & Toxicology|July 2, 2026
Contribution of Countries and International Collaboration in Clinical Pharmacology Research. A Cross-Sectional Bibliometric Study of Six Top Ranked Specialty Society JournalsRafael Dal-Ré, Lucía Llanos, Ignacio Mahillo-Fernández
European Journal of Clinical Pharmacology|September 14, 2017
Who is willing to participate in low-risk pragmatic clinical trials without consent?Rafael Dal-Ré, Antonio J Carcas, Xavier Carné
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 8, 2022
Heterologous COVID-19 Vaccination in Spain: A Case Study of Individual Autonomy in the Real WorldRafael Dal-Ré, Magí Farré, M Isabel Lucena
Journal of Global Health|January 19, 2023
How WHO Solidarity Plus trial participants in countries on four continents are informed in writingRafael Dal-Ré, Teck Chuan Voo, Søren Holm
Journal of Global Health|May 11, 2023
Adaptive, platform trials assessing therapies for hospitalized COVID-19 patients: Informed consent forms omitted a few important elements of informationRafael Dal-Ré, Teck Chuan Voo, Søren Holm
BMC Medicine|April 5, 2018
Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?Rafael Dal-Ré, Perrine Janiaud, John P A Ioannidis
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|March 23, 2021
Thoughtful selection and use of scientific terms in clinical research: the case of 'pragmatic' trialsRafael Dal-Ré, Robert J Mentz, Frits R Rosendaal
European Journal of Clinical Pharmacology|January 9, 2025
Features and results availability of non-commercial Spanish COVID-19 trials: a systematic review of clinical trial registers and corresponding literatureRafael Dal-Ré, Elena García-Méndez, Ignacio Mahillo-Fernández
British Journal of Clinical Pharmacology|January 9, 2016
The potential exploitation of research participants in high income countries who lack access to health careRafael Dal-Ré, Annette Rid, Ezekiel Emanuel, et al.
Pageof 8